Overexpression of caspase-1 in aorta of patients with coronary atherosclerosis

Heart Lung and Circulation

Volumn 23, Issue 11, 2014, Pages 1070-1074

  Zheng, Fei ^a   Gong, Zushun ^a   Xing, Shanshan ^b   Xing, Qichong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Atherosclerosis; Caspase 1; Coronary artery bypass graft; Inflammasome; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AORTA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HUMAN; HUMAN TISSUE; HYPERTENSION; MALE; PROTEIN EXPRESSION; SMOKING; AGED; BIOSYNTHESIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATHOLOGY;

AGED; AORTA; CASPASE 1; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 84910019672     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.04.256     Document Type: Article

References (21)

1. Lloyd-Jones D.M. Cardiovascular Risk Prediction Basic Concepts, Current Status, and Future Directions. Circulation 2010, 121:1768-1777.
2. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
3. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352:1685-1695.
4. Chen G.Y., Nuñez G. Sterile inflammation: sensing and reacting to damage. Nature Reviews Immunology 2010, 10:826-837.
5. Davis B.K., Wen H., Ting J.P.Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011, 29:707-735.
6. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
7. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006, 86:515-581.
8. Kirii H., Niwa T., Yamada Y., Wada H., Saito K., Iwakura Y., et al. Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003, 23:656-660.
9. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
10. Usui F., Shirasuna K., Kimura H., Tatsumi K., Kawashima A., Karasawa T., et al. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2012, 425:162-168.
11. Gage J., Hasu M., Thabet M., Whitman S.C. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can J Cardiol. 2012, 28:222-229.
12. Zheng F., Xing S., Gong Z., Xing Q. NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart, Lung and Circulation. 2013, 22:746-750.
13. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. The American Journal of Cardiology. 1983, 51:606.
14. Lundberg A.M., Hansson G.K. Innate immune signals in atherosclerosis. Clinical Immunology (Orlando, Fla) 2010, 134:5.
15. Lundberg A.M., Yan Z.Q. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation. Curr Opin Lipidol. 2011, 22:343-349.
16. Wright S.D., Burton C., Hernandez M., Hassing H., Montenegro J., Mundt S., et al. Infectious agents are not necessary for murine atherogenesis. The Journal of Experimental Medicine. 2000, 191:1437-1442.
17. Goldstein J., Brown M. Lipoprotein receptors, cholesterol metabolism, and atherosclerosis. Arch Pathol. 1975, 99:181.
18. Rajamäki K., Lappalainen J., Öörni K., Välimäki E., Matikainen S., Kovanen P.T., et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One. 2010, 5:e11765.
19. Menu P., Pellegrin M., Aubert J.F., Bouzourene K., Tardivel A., Mazzolai L., et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis. 2011, 2:e137.
20. Zhu P., Li X., Shi H. Correlation analysis on the degrees of atherosclerosis between coronary artery and aorta in autopsied cases with cardiovascular diseases. Chinese Journal of Cardiology 2004, 32:486-488.
21. Fazio G.P., Redberg R.F., Winslow T., Schiller N.B. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol. 1993, 21:144-150.